Sage Therapeutics, Inc. (Nasdaq: SAGE), a pioneering biopharmaceutical company dedicated to improving brain health, is proud to announce its participation in the Stifel 2023 CNS Days on Wednesday, March 29th.
Join us at 11:00 a.m. ET to learn more about how we are revolutionizing the way we approach brain health and discover the groundbreaking treatments that are set to shape the future of neuroscience.
About Sage Therapeutics
At Sage Therapeutics, we are boldly striving to make the world a better place with improved brain health. Our goal is to revolutionize the treatment of brain health by introducing innovative medicines that will dramatically improve people’s lives. We are passionate about helping people and are dedicated to making a difference in the lives of those suffering from brain health issues.